Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA3 | P07451 | 2/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA6 | P23280 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.34 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.32 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27467443 | 1.00 | GSR (0.39) | GSRCA12CA1CA2CA3 | |
| SCHEMBL28194694 | 1.00 | GSR (0.39) | GSRCA12CA1CA2CA3 | |
| SCHEMBL28880358 | 0.98 | GSR (0.40) | GSRCA12CA1CA2CA3 | |
| SCHEMBL12386354 | 0.98 | GSR (0.40) | GSRCA12CA1CA2CA3 | |
| SCHEMBL12386352 | 0.98 | GSR (0.40) | GSRCA12CA1CA2CA3 | |
| SCHEMBL5868349 | 0.81 | — | — | |
| SCHEMBL323070 | 0.81 | OPRM1 (0.43) | LMNABLM | |
| SCHEMBL5968272 | 0.81 | OPRM1 (0.43) | LMNABLM | |
| SCHEMBL28838066 | 0.81 | OPRM1 (0.43) | LMNABLM | |
| SCHEMBL28057452 | 0.79 | OPRM1 (0.41) | LMNABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0754189-B1 | RECEPTOR MODULATING AGENTS AND METHODS RELATING THERETO | RECEPTAGEN CORP (US) | 2002-10-09 | — | — | EP | disclosed |
| EP-1015475-A1 | VITAMIN B 12? RECEPTOR MODULATING AGENTS AND METHODS RELATED THERETO | RECEPTAGEN CORPORATION (US) | 2000-07-05 | — | — | EP | disclosed |
| US-6083926-A | AGENT COMPRISED OF VITAMIN B12 COVALENTLY COUPLED TO BIOTIN BY WATER-SOLUBLE LINKER | THE UNIVERSITY OF WASHINGTON (US) | 2000-07-04 | — | — | US | disclosed |
| US-5869465-A | BINDING TO CELL SURFACE RECEPTORS AND AFFECTING THEIR TRAFFICKING PATHWAY FOR THE TREATMENT AND DIAGNOSIS OF DISORDERS IN WARM-BLOODED ANIMALS | RECEPTAGEN CORPORATION (US) | 1999-02-09 | — | — | US | disclosed |
| US-5840712-A | TARGETS AND LINKERS | RECEPTAGEN CORPORATION (US) | 1998-11-24 | — | — | US | disclosed |
| US-5840880-A | VITAMIN B12 DIMER | RECEPTAGEN CORPORATION (US) | 1998-11-24 | — | — | US | disclosed |
| US-5739287-A | BOUND ALSO TO A RECEPTOR MODULATING AGENT TO IMPEDE CELL SURFACE RECEPTOR TRAFFICKING PATHWAYS BY INHIBITING THE RECYCLING OF RECEPTORS TO THE CELL SURFACE; ANTITUMOR AND -CARCINOGENIC AGENTS; LEUKEMIA | UNIVERSITY OF WASHINGTON (US) | 1998-04-14 | — | — | US | disclosed |
| WO-1997014711-A9 | VITAMIN B12 RECEPTOR MODULATING AGENTS AND METHODS RELATED THERETO | — | 1997-10-02 | — | — | WO | disclosed |
| WO-1997014711-A1 | VITAMIN B12 RECEPTOR MODULATING AGENTS AND METHODS RELATED THERETO | RECEPTAGEN CORPORATION (US) | 1997-04-24 | — | — | WO | disclosed |
| EP-0754189-A1 | RECEPTOR MODULATING AGENTS AND METHODS RELATING THERETO | RECEPTAGEN CORPORATION (US) | 1997-01-22 | — | — | EP | disclosed |
| WO-1995027723-A1 | RECEPTOR MODULATING AGENTS AND METHODS RELATING THERETO | RECEPTAGEN CORPORATION (US) | 1995-10-19 | — | — | WO | disclosed |